Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Atara Biotherapeutics (ATRA) Gains from Sales and Divestitures (2019 - 2020)

Updated

Atara Biotherapeutics (ATRA) posted Gains from Sales and Divestitures of -$21,000 for Q4 2021, compared with -$37,000 a year earlier.

Analysis

Atara Biotherapeutics (ATRA) Gains from Sales and Divestitures (2019 - 2020) Analysis & Trends

Since Q3 2019, Atara Biotherapeutics has reported Gains from Sales and Divestitures for 4 quarters.

  • In prior years, Atara Biotherapeutics' Gains from Sales and Divestitures was -$130,000 in FY2020 and -$1.03 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Atara Biotherapeutics 124.14 Mn 114.24 Mn 959,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 93,000.00
Dec 31, 2019 -100,000.00
Sep 30, 2019 -800,000.00
API Access

Atara Biotherapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ATRA&period=max&api_key=YOUR_API_KEY